Literature DB >> 6840842

Pseudomembranous colitis in Clostridium difficile-monoassociated rats.

C J Czuprynski, W J Johnson, E Balish, T Wilkins.   

Abstract

Germfree rats were monoassociated with either a toxin-producing strain of Clostridium difficile (Tox+) or a variant of this strain (ToxR) which produced much less toxin (1/10,000) in vivo and in vitro. Monoassociation of germfree rats with C. difficile Tox+ resulted in mortality (17%) and in pathology to the small and large intestines, livers, and lungs. Cecal filtrates from the Tox+-monoassociated rats were cytotoxic for tissue culture cells. The cytotoxicity of cecal filtrates could be blocked by sera from Tox+-monoassociated rats. Monoassociation of rats with C. difficile ToxR resulted in no deaths or pathology, and much less toxin was detected in the cecal filtrates of these animals than in those of rats colonized with the Tox+ strain. This gnotobiotic model may be useful for investigating the etiology, prophylaxis, therapy, and exacerbation of C. difficile-induced pseudomembranous colitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840842      PMCID: PMC348107          DOI: 10.1128/iai.39.3.1368-1376.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Intoxication of cultured human lung fibroblasts with Clostridium difficile toxin.

Authors:  I Florin; M Thelestam
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

2.  Cytotoxicity of several marketed antibiotics on mammalian cells in culture.

Authors:  L H Li; S L Kuentzel; K D Shugars; B K Bhuyan
Journal:  J Antibiot (Tokyo)       Date:  1977-06       Impact factor: 2.649

3.  Effects of Clostridium difficile toxin on tissue-cultured cells.

Authors:  S T Donta; S J Shaffer
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

Review 4.  Clostridia and antimicrobial enterocolitis.

Authors:  J Silva; R Fekety
Journal:  Annu Rev Med       Date:  1981       Impact factor: 13.739

5.  Experimental reproduction of neonatal diarrhea in young gnotobiotic hares simultaneously associated with Clostridium difficile and other Clostridium strains.

Authors:  J Dabard; F Dubos; L Martinet; R Ducluzeau
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  Presence of Clostridium difficile toxin in guinea pigs with penicillin-associated colitis.

Authors:  S W Rothman
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

7.  Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Authors:  D L Vesely; K D Straub; C M Nolan; R D Rolfe; S M Finegold; T P Monson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  Clindamycin-induced enterocolitis in hamsters.

Authors:  R H Lusk; R Fekety; J Silva; R A Browne; D H Ringler; G D Abrams
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

9.  Pathogenesis of Listeria monocytogenes for gnotobiotic rats.

Authors:  C J Czuprynski; E Balish
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Antibiotic-induced colitis implication of a toxin neutralised by Clostridium sordellii antitoxin.

Authors:  G D Rifkin; F R Fekety; J Silva
Journal:  Lancet       Date:  1977-11-26       Impact factor: 79.321

View more
  19 in total

1.  Mouse relapse model of Clostridium difficile infection.

Authors:  Xingmin Sun; Haiying Wang; Yongrong Zhang; Kevin Chen; Barbara Davis; Hanping Feng
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

Review 2.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Intestinal multiplication of Mycobacterium paratuberculosis in athymic nude gnotobiotic mice.

Authors:  H L Hamilton; D M Follett; L M Siegfried; C J Czuprynski
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

4.  The non-toxigenic Clostridium difficile CD37 protects mice against infection with a BI/NAP1/027 type of C. difficile strain.

Authors:  Keshan Zhang; Song Zhao; Yuankai Wang; Xuejun Zhu; Hong Shen; Yugen Chen; Xingmin Sun
Journal:  Anaerobe       Date:  2015-10-13       Impact factor: 3.331

5.  Prairie dog model for antimicrobial agent-induced Clostridium difficile diarrhea.

Authors:  E L Muller; H A Pitt; W L George
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

6.  Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria.

Authors:  G Corthier; F Dubos; P Raibaud
Journal:  Appl Environ Microbiol       Date:  1985-01       Impact factor: 4.792

7.  Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.

Authors:  S Mahe; G Corthier; F Dubos
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

8.  Emergence in gnotobiotic mice of nontoxinogenic clones of Clostridium difficile from a toxinogenic one.

Authors:  G Corthier; M C Muller
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

9.  Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.

Authors:  D C Dailey; A Kaiser; R H Schloemer
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

10.  Protection against experimental pseudomembranous colitis in gnotobiotic mice by use of monoclonal antibodies against Clostridium difficile toxin A.

Authors:  G Corthier; M C Muller; T D Wilkins; D Lyerly; R L'Haridon
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.